Initial testing (stage 1) of M6620 (formerly VX‐970), a novel ATR inhibitor, alone and combined with cisplatin and melphalan, by the Pediatric Preclinical Testing Program
Raushan T. Kurmasheva; Dias Kurmashev; C. Patrick Reynolds; Min Kang; Jianwrong Wu; Peter J. Houghton; Malcolm A. Smith
Author Information: Center for Childhood Cancer and Blood Diseases, Nationwide Children's Hospital
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.